Overactive Bladder Treatment Market Share

Statistics for the 2023 & 2024 Overactive Bladder Treatment market share, created by Mordor Intelligence™ Industry Reports. Overactive Bladder Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Overactive Bladder Treatment Industry

The overactive bladder treatment market is moderately competitive due to the presence of several players in the market. Some of the key players in the market are AbbVie Inc., Astellas Pharma Inc., Laborie, Endo International PLC, Hisamitsu Pharmaceutical Co., Inc., and Macleods, among others.

Overactive Bladder Treatment (OAB) Market Leaders

  1. Medtronic PLC

  2. Astellas Pharma, Inc.

  3. Macleods Pharmaceuticals Ltd

  4. Pfizer, Inc

  5. AbbVie Ltd.

*Disclaimer: Major Players sorted in no particular order

Overactive Bladder Treatment Market Concentration

Overactive Bladder Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)